slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 28,771-28,800
Pages 1,418
Rows per page 30
Beat
28,771-28,800 of 42,534
91
The slide contrasts human perception (Simvastatin looks like a rescue) with machine learning results (Cholecalciferol and REC-994 show rescue).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
92
Slide 92 of a presentation deck.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
93
The slide uses a before-after-bridge structure to explain the therapeutic mechanism of REC-994 in the context of CCM.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
94
The table compares Placebo against 50mg, 200mg, 400mg, and 800mg doses across various safety metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
95
The slide outlines a randomized controlled trial structure with three arms (400mg, 200mg, placebo) followed by a 12-month treatment period.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
96
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
97
Includes a patient photo and source citation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
98
The slide uses a pie chart to segment the patient population and an MRI scan to illustrate the clinical problem.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
99
The slide uses a combination of quantitative scatter plot data and qualitative imaging to demonstrate drug efficacy.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
100
The slide uses a numbered process flow to explain the mechanism of action of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
101
The slide uses a split-screen layout to compare two different preclinical efficacy studies.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
102
Slide 102 from a presentation deck.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
103
The diagram uses a layered arrow approach to show cumulative advantages.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
104
The slide uses a process flow diagram to illustrate the clinical trial stages for Cohort A (Phase 2) and Cohort B (Phase 3).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
105
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
106
The slide uses a medical image of polyps to illustrate the condition.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
107
Includes a medical illustration of colonoscopy and a quote from a medical professional.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
108
The chart shows a 'rescue' effect where the drug moves the disease state (red) closer to the healthy state (green).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
109
The slide uses a before-after framework to illustrate the mechanism of action (MoA) of a drug candidate.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
110
The slide uses two distinct chart types (bar chart with error bars and dot plot with mean/SEM bars) to demonstrate efficacy across two metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
111
Clinical: FAP context. Slide 111.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
112
The slide outlines a two-part clinical trial design (Part 1 and Part 2) with specific enrollment criteria and outcome measures.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
113
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
114
Includes a testimonial/quote from a KOL regarding the lack of therapeutic relevance in HCC.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
115
The slide uses a table to quantify the addressable market and a callout box to link preclinical data to the study design.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
116
The slide uses a heatmap to demonstrate biological similarity between drug dosage effects and specific gene regulation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
117
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
118
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
119
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
120
The slide uses a three-step process diagram to illustrate the biological mechanism of C. diff infection.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit